Philips and Masimo extend strategic partnership with sensor tech focus

Philips and MASIMO have renewed a long -term strategic partnership to develop patient care solutions.

This time, companies stated that their cooperation will mainly focus on the patient’s access to monitoring and measurement techniques, with more integrated tools that support “better results through the sponsorship chain”.

It will be one of the basic aspects of corporate plans to integrate MASIMO sensors techniques, set the pulse oximation measurement, and PPG Radius tools on Patient Patient Monitoring Platforms in Philips.

According to companies, the planned integration of doctors with reliable data and visions will be provided via bed screens, central stations and wearable solutions. The technology resulting from interconnection and support for the continuity of patient care will enhance.

“The expansion of our strong partnership with Philips allows us to build on our joint heritage in innovation and helps to ensure that the best MASIMO technology in its class reaches more patients.”

By developing this unified basis, companies also plan to cooperate in solutions to monitoring the next generation, and they reflect the emerging clinical needs and advanced demand in the market such as the need to increase the patient’s transportation.

“Our priority is to help doctors provide the best possible care for their patients, and this means staying at the top of the curve,” commented Julia Strandberg, CEO and business leader at Connection Care in Philips.

In July, Philips renewed a similar relationship with Medrtonic to help perceive what Sachin Chaudhari, General Manager of Philips for Clinical Applications and Patient Watch in Hospitals, was based on a “most comprehensive” patient monitoring solution.

MEDTRONIC itself has recently signed a similar partnership with the MFT National Health Corporation (NHS) to participate in developing health care technologies, including a remote monitoring path called Tricehp Plus. According to the Globaldata analysis, the patient monitoring market is expected to grow by 2.1 % to reach an evaluation of $ 26 billion by 2034, up from $ 20.9 billion in 2024.

“Philips and MASIMO ExtRing Partnership was originally created with Sensor Tech Focus” and published by the Medical Device network, a brand owned by Globaldata.

Information on this site was included in good faith for public media purposes only. It is not intended to reach the advice that you should depend on, and we do not provide any representation, guarantee or guarantee, whether it is explicit or implicit in relation to accurately or completing it. You must have a professional or specialized advice before taking any action based on the content on our website.